APGE

Apogee Therapeutics Inc
CAPPED RATING

Apogee Therapeutics, Inc., through its subsidiary, operates as a biotechnology company that develops biologics for the treatment of atopic dermatitis (AD), chronic obstructive pulmonary disease (COPD), and related inflammatory and immunology indications. The company primarily develops APG777, a subcutaneous (SQ) extended half-life monoclonal antibody (mAb) for AD; and APG808, an SQ extended half-life mAb for COPD. Its earlier-stage programs include APG990, an SQ extended half-life mAb for the treatment of AD; and APG222, an extended half-life SQ antibodies for AD. The company was founded in 2022 and is based in Waltham, Massachusetts.

Apogee Therapeutics Inc (APGE) is rated C (2.4/5) on Deltasharpe Prism, scored against Healthcare sector peers. Its strongest pillar is Profitability (C+); its weakest is Growth (D+).

Quantitative Factor Evaluation • Updated

Overall Rating
2.4 / 5.0
C
Value
C+
Factor Score 2.5 / 5.0
Growth
D+
Factor Score 1.7 / 5.0
Profitability
C+
Factor Score 2.7 / 5.0
Momentum
C+
Factor Score 2.5 / 5.0
Revisions
C+
Factor Score 2.6 / 5.0

Prism grades are automated quantitative screens, not buy, sell or hold recommendations, and not investment advice. Data may be delayed or contain errors. Terms

Ratings of B- and above are for members.

Register free to see every rating — your first 2 weeks of Premium are on us.

Register — 2 weeks free

Underlying Financial Metrics

P/E Ratio -26.0
EV / EBITDA -28.6
Rev Growth YoY N/A
Gross Margin 0.0%
Price Return 3M N/A
Price Return 12M N/A
Catalyst Signal 0.00
Market Cap $10.2B
TTM Revenue N/A
Price / Sales N/A
ROE -32.5%

Historical Factor Score Progression

Date Value Growth Profitability Momentum Revisions Overall
2026-11-17 C+ (2.5) D+ (1.7) C+ (2.7) C+ (2.5) C+ (2.6) C (2.4)
2026-11-10 C+ (2.5) D+ (1.7) C+ (2.7) C+ (2.5) F (0.0) C- (1.9)
2026-11-03 C+ (2.5) D+ (1.6) C+ (2.7) C+ (2.5) F (0.0) C- (1.9)
2026-10-27 C+ (2.5) D+ (1.6) C+ (2.7) C+ (2.5) F (0.0) C- (1.9)
2026-10-20 C+ (2.5) D+ (1.6) C+ (2.7) C+ (2.5) F (0.0) C- (1.9)
Page 1 of 4